Literature DB >> 2149819

Mastectomy or breast conservation in the management of primary breast cancer: psychosocial factors.

W H Wolberg1.   

Abstract

A diagnosis of breast cancer causes significant emotional, social, and vocational upheaval which diminishes over time. However, newly diagnosed breast cancer patients are mentally capable of making treatment decisions and should be offered the available treatment options. A significant proportion of patients who have the option of breast conservation will choose mastectomy instead. Saving the breast does not significantly alter adjustment problems.

Entities:  

Mesh:

Year:  1990        PMID: 2149819

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  5 in total

1.  The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

Authors:  Lisa C Richardson; Lili Tian; Lydia Voti; Abraham G Hartzema; Isildinha Reis; Lora E Fleming; Jill Mackinnon
Journal:  Am J Public Health       Date:  2005-11-29       Impact factor: 9.308

2.  Patient satisfaction with decision-making for breast cancer therapy.

Authors:  S M Weiss; P A Wengert; E M Martinez; W Sewall; E Kopp
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

3.  Participation in treatment decision-making by women with early stage breast cancer.

Authors:  Patricia Kenny; Susan Quine; Alan Shiell; Sue Cameron
Journal:  Health Expect       Date:  1999-09       Impact factor: 3.377

4.  Prospective hospital-based survey of attitudes of Southern women toward surgical treatment of breast cancer.

Authors:  J P Wei; R M Sherry; B L Baisden; J Peckel; G Lala
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

5.  Case-mix fails to explain variation in mastectomy rates: management of screen-detected breast cancer in a UK region 1997-2003.

Authors:  L J M Caldon; S J Walters; J A Reed; A Murphy; A Worley; M W R Reed
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.